SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness

Acute myeloid leukemia (AML) is a heterogeneous disease with respect to its genetic and molecular basis and to patients´ outcome. Clinical, cytogenetic, and mutational data are used to classify patients into risk groups with different survival, however, within-group heterogeneity is still an issue....

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Chi Huu, Glüxam, Tobias, Schlerka, Angela, Bauer, Katharina, Grandits, Alexander M., Hackl, Hubert, Dovey, Oliver, Zöchbauer-Müller, Sabine, Cooper, Jonathan L., Vassiliou, George S., Stoiber, Dagmar, Wieser, Rotraud, Heller, Gerwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591510/
https://www.ncbi.nlm.nih.gov/pubmed/31235852
http://dx.doi.org/10.1038/s41598-019-45579-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591510/
https://www.ncbi.nlm.nih.gov/pubmed/31235852
http://dx.doi.org/10.1038/s41598-019-45579-0

Ejemplares similares